The observed loss of FOXA2 expression in poorly differentiated endometrial carcinomas and our FOXA2 reexpression studies (which revealed significant roles in cancer cell growth and promotion of cell adhesion to extracellular matrix factors) provoked the question of whether FOXA2 plays a role in EMT. Here, FOXA2 is linked to endometrial carcinoma.